AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2014
Sep 13, 2014
30786_dirs_2014-09-12_fbea6771-1292-47ce-a034-2c4b81b72e36.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2014-09-10
Reporting Person: SODERBERG SHAWN MARIE (EVP, General Counsel, Sec)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-09-10 | Non-Qualified Stock Option (right to buy) | $119.54 | A | 3000 | Acquired | 2024-09-10 | Bio-Rad A Common Stock (3000) | Direct |
| 2014-09-10 | Restricted Stock Units | $0 | A | 2000 | Acquired | Bio-Rad A Common Stock (2000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 0 | Direct |
Footnotes
F1: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13